Benzinga |
Alexion Pharmaceuticals Hits New 52-Week Highs at $52.67
Many traders and investors see the 52-week high or low as an important indicator.
Stocks that have a long-term trend in a certain direction are likely to continue, as that trend is the path of least resistance.In this case, shares of Alexion Pharmaceuticals (NASDAQ: ALXN) are hitting new 52-week highs.
After That Release, Should Goldman Be Downgraded To Silverman?
That was nothing short of a brutal earnings report from Goldman Sachs (NYSE: GS) and is worth of asking whether the prestigious investment bank has lost its luster on Wall Street.
The New York-based investment bank reported earnings of $1.85 per share on $7.28 billion in revenues. Wall Street analysts had been expecting earnings of $2.27 per share on $8.14 billion in revenues.
Expenses plunged during the quarter, dropping 23.3% as worries continue to persist that the bank will lay off employees to decrease headcount, as fixed income, currency and commodities trading revenue fell 53% to $1.6 billion.
“During the second quarter, the operating environment was more difficult given global macro-economic concerns,” said Lloyd C. Blankfein, Chairman and Chief Executive Officer. “In addition, certain of our businesses had disappointing results as we reduced our market risk in response to attempting to manage fluctuations in prices and market liquidity. Despite these challenges, we continued to address our clients' needs through our strong global franchise...
After That Release, Should Goldman Be Downgraded To Silverman?
That was nothing short of a brutal earnings report from Goldman Sachs (NYSE: GS) and is worth of asking whether the prestigious investment bank has lost its luster on Wall Street.
The New York-based investment bank reported earnings of $1.85 per share on $7.28 billion in revenues. Wall Street analysts had been expecting earnings of $2.27 per share on $8.14 billion in revenues.
Expenses plunged during the quarter, dropping 23.3% as worries continue to persist that the bank will lay off employees to decrease headcount, as fixed income, currency and commodities trading revenue fell 53% to $1.6 billion.
“During the second quarter, the operating environment was more difficult given global macro-economic concerns,” said Lloyd C. Blankfein, Chairman and Chief Executive Officer. “In addition, certain of our businesses had disappointing results as we reduced our market risk in response to attempting to manage fluctuations in prices and market liquidity. Despite these challenges, we continued to address our clients' needs through our strong global franchise...
After That Release, Should Goldman Be Downgraded To Silverman?
That was nothing short of a brutal earnings report from Goldman Sachs (NYSE: GS) and is worth of asking whether the prestigious investment bank has lost its luster on Wall Street.
The New York-based investment bank reported earnings of $1.85 per share on $7.28 billion in revenues. Wall Street analysts had been expecting earnings of $2.27 per share on $8.14 billion in revenues.
Expenses plunged during the quarter, dropping 23.3% as worries continue to persist that the bank will lay off employees to decrease headcount, as fixed income, currency and commodities trading revenue fell 53% to $1.6 billion.
“During the second quarter, the operating environment was more difficult given global macro-economic concerns,” said Lloyd C. Blankfein, Chairman and Chief Executive Officer. “In addition, certain of our businesses had disappointing results as we reduced our market risk in response to attempting to manage fluctuations in prices and market liquidity. Despite these challenges, we continued to address our clients' needs through our strong global franchise...
